Nicolas Ansermot

1.4k total citations
41 papers, 1.0k citations indexed

About

Nicolas Ansermot is a scholar working on Pharmacology, Psychiatry and Mental health and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Nicolas Ansermot has authored 41 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pharmacology, 12 papers in Psychiatry and Mental health and 9 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Nicolas Ansermot's work include Pharmacogenetics and Drug Metabolism (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Coffee research and impacts (6 papers). Nicolas Ansermot is often cited by papers focused on Pharmacogenetics and Drug Metabolism (7 papers), Pharmacological Effects and Toxicity Studies (6 papers) and Coffee research and impacts (6 papers). Nicolas Ansermot collaborates with scholars based in Switzerland, United States and Belgium. Nicolas Ansermot's co-authors include Chin B. Eap, Séverine Crettol, Marlyse Brawand-Amey, Beatrice Oneda, Marc Fathi, Muriel Noetzli, Serge Rudaz, Jean‐Luc Veuthey, Jules Desmeules and Murielle Bochud and has published in prestigious journals such as SHILAP Revista de lepidopterología, Hypertension and Journal of Chromatography A.

In The Last Decade

Nicolas Ansermot

36 papers receiving 980 citations

Peers

Countries citing papers authored by Nicolas Ansermot

Since Specialization

Citations

This map shows the geographic impact of Nicolas Ansermot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolas Ansermot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolas Ansermot more than expected).

Fields of papers citing papers by Nicolas Ansermot

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolas Ansermot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolas Ansermot. The network helps show where Nicolas Ansermot may publish in the future.

Co-authorship network of co-authors of Nicolas Ansermot

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolas Ansermot. A scholar is included among the top collaborators of Nicolas Ansermot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolas Ansermot. Nicolas Ansermot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Self-reported caffeine consumption miss-matched consumption measured by plasma levels of caffeine and its metabolites: results from two population-based studies 2024 ·European Journal of Nutrition ·(unknown), Setareh Ranjbar, Marie‐Pierre F. Strippoli, Pedro Marques‐Vidal, (unknown), Belén Ponte, Menno Pruijm, Bruno Vogt, Nicolas Ansermot, Séverine Crettol, Frederik Vandenberghe, Péter Vollenweider, Martin Preisig, Murielle Bochud, Chin B. Eap	0
2	Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis 2023 ·Molecular Psychiatry ·Jennifer Sjaarda, (unknown), (unknown), (unknown), (unknown), (unknown), Frederik Vandenberghe, Séverine Crettol, Nicolas Ansermot, Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Zoltán Kutalik, Chin B. Eap	8
3	Psychotropic Drug Prescription in Children and Adolescents: Approved Medications in European Countries and the United States 2022 ·Journal of Child and Adolescent Psychopharmacology ·(unknown), (unknown), Kerstin Jessica Plessen, Chin B. Eap, Nicolas Ansermot	10
4	Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort 2022 ·BMC Psychiatry ·(unknown), (unknown), Setareh Ranjbar, (unknown), (unknown), (unknown), (unknown), Hélène Richard-Lepouriel, Nicolas Ansermot, Séverine Crettol, Frederik Vandenberghe, (unknown), (unknown), Franziska Gamma, Kerstin Jessica Plessen, Armin von Gunten, Philippe Conus, Chin B. Eap	12
5	Case Report: Opioid Use Disorder Associated With Low/Moderate Dose of Loperamide in an Intellectual Disability Patient With CYP3A and P-Glycoprotein Reduced Activity 2022 ·Frontiers in Psychiatry ·Vincent Guinchat, Nicolas Ansermot, Kuntheavy Ing Lorenzini, (unknown), Youssef Daali, Chin B. Eap, Séverine Crettol	1
6	Psychotropic Drug Prescription in Adolescents: A Retrospective Study in a Swiss Psychiatric University Hospital 2017 ·Journal of Child and Adolescent Psychopharmacology ·Nicolas Ansermot, (unknown), (unknown), Laurent Holzer, Chin B. Eap	4
7	Stereoselective determination of citalopram and desmethylcitalopram in human plasma and breast milk by liquid chromatography tandem mass spectrometry 2016 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Alice Panchaud, Kim An Nguyen, (unknown), Jean‐Michel Hascoët, Chantal Csajka, Chin B. Eap, Nicolas Ansermot	15
8	Relation of 24-hour urinary caffeine and caffeine metabolite excretions with self-reported consumption of coffee and other caffeinated beverages in the general population 2016 ·Nutrition & Metabolism ·Dušan Petrović, (unknown), Menno Pruijm, Belén Ponte, Daniel Ackermann, Georg Ehret, Nicolas Ansermot, Markus G. Mohaupt, Fred Paccaud, Bruno Vogt, Antoinette Péchère-Bertschi, Pierre‐Yves Martin, Michel Burnier, Chin B. Eap, Murielle Bochud, Idris Guessous	20
9	Fast quantification of ten psychotropic drugs and metabolites in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring 2013 ·Journal of Chromatography A ·Nicolas Ansermot, Marlyse Brawand-Amey, (unknown), Chin B. Eap	74
10	Quantification of typical antipsychotics in human plasma by ultra-high performance liquid chromatography tandem mass spectrometry for therapeutic drug monitoring 2013 ·Journal of Pharmaceutical and Biomedical Analysis ·Julieta Gradinaru, (unknown), Chin B. Eap, Nicolas Ansermot	32
11	Buprenorphine and norbuprenorphine quantification in human plasma by simple protein precipitation and ultra-high performance liquid chromatography tandem mass spectrometry 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), (unknown), Chin B. Eap, Nicolas Ansermot	21
12	Simultaneous determination of antidementia drugs in human plasma: Procedure transfer from HPLC–MS to UPLC–MS/MS 2012 ·Journal of Pharmaceutical and Biomedical Analysis ·Muriel Noetzli, Nicolas Ansermot, Maria Dobrinas, Chin B. Eap	48
13	Quantification of nicotine, cotinine, trans-3′-hydroxycotinine and varenicline in human plasma by a sensitive and specific UPLC–tandem mass-spectrometry procedure for a clinical study on smoking cessation 2011 ·Journal of Chromatography B ·Maria Dobrinas, Eva Choong, Muriel Noetzli, Jacques Cornuz, Nicolas Ansermot, Chin B. Eap	37
14	Simultaneous Determination of Antidementia Drugs in Human Plasma for Therapeutic Drug Monitoring 2011 ·Therapeutic Drug Monitoring ·Muriel Noetzli, Eva Choong, Nicolas Ansermot, Chin B. Eap	24
15	The P450 oxidoreductase genotype is associated with CYP3A activity in vivo as measured by the midazolam phenotyping test 2009 ·Pharmacogenetics and Genomics ·Beatrice Oneda, Séverine Crettol, (unknown), Murielle Bochud, Nicolas Ansermot, Chin B. Eap	96
16	ABCB1 and Cytochrome P450 Polymorphisms 2009 ·Journal of Clinical Psychopharmacology ·E Jaquenoud Sirot, (unknown), (unknown), (unknown), Beatrice Oneda, Séverine Crettol, Nicolas Ansermot, Pierre Baumann, Chin B. Eap	105
17	Validation and long-term evaluation of a modified on-line chiral analytical method for therapeutic drug monitoring of (R,S)-methadone in clinical samples 2009 ·Journal of Chromatography B ·Nicolas Ansermot, Serge Rudaz, Marlyse Brawand-Amey, Sandrine Fleury‐Souverain, Jean‐Luc Veuthey, Chin B. Eap	14
18	Quantification of cyclosporine and tacrolimus in whole blood. Comparison of liquid chromatography–electrospray mass spectrometry with the enzyme multiplied immunoassay technique 2008 ·Clinical Biochemistry ·Nicolas Ansermot, Marc Fathi, Jean‐Luc Veuthey, Jules Desmeules, Serge Rudaz, Denis F. Hochstrasser	46
19	Influence of ABCB1 Gene Polymorphisms and P-Glycoprotein Activity on Cyclosporine Pharmacokinetics in Peripheral Blood Mononuclear Cells in Healthy Volunteers 2008 ·Drug Metabolism Letters ·Nicolas Ansermot, Michela Rebsamen, Jocelyne Chabert, Marc Fathi, Marianne Gex‐Fabry, Youssef Daali, Marie Besson, Michel F. Rossier, Serge Rudaz, Denis F. Hochstrasser, Pierre Dayer, Jules Desmeules	29
20	Quantification of cyclosporine A in peripheral blood mononuclear cells by liquid chromatography-electrospray mass spectrometry using a column-switching approach 2007 ·Journal of Chromatography B ·Nicolas Ansermot, Mohammad Reza Fat’hi, Jean‐Luc Veuthey, Jules Desmeules, D Hochstrasser, Serge Rudaz	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact